Diagnostics-World
Twitter   LinkedIn Facebookinstagram RSS  
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • Post a Press Release
    • View Press Releases
    • Submit a Story
    • Reprint Articles
  • Advertise
    • Media Kit
    • Digital Advertising Opportunities
    • Lead Generation
    • Whitepapers
    • Webinars
    • Podcasts
    • Editorial Calender
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside Ebooks
  • Events
    • Webinars
    • Industry Events
    • Dx Conferences
    • Tri-Conference
    • Next Generation Dx
    • Dx Innovation Summit
  • About
    • Editorial Profile
    • Editorial Calender
    • Contact
  • Molecular Med Tri-Conference
 
  • IBM's Watson Supercomputer Leading Charge Into Early Melanoma Detection

    Australian Financial Review | IBM is breaking ground in the early detection of skin cancer using its Watson supercomputer.

    Mar 10, 2017
  • SelectMDx Chosen By Michigan Medicine As Pre-biopsy Diagnostic Tool In Prostate Cancer Risk Clinic

    Diagnostics World Brief | MDxHealth announced that SelectMDx for Prostate Cancer will be used for the newly launched prostate cancer risk clinic at the University of Michigan.

    Mar 9, 2017
  • Proscia And Samsung Medical Center Partner Up To Develop Diagnostic Tests

    Diagnostics World | Proscia, a digital pathology provider, has entered a partnership with Samsung Medical Center, hoping to develop diagnostic tests that are computer- and image-based.

    Mar 8, 2017
  • How Genetic Testing Can Be Like A Placebo

    Forbes | It would be ironic, certainly, if the primary benefit of many genetic tests proves to be behavioral, but what's the harm, especially if it's paid for by consumers? The unacceptable cost of eroding trust in the underlying science.

    Mar 3, 2017
  • GRAIL Closes Initial Investment To Develop Blood Tests To Detect Cancer Early

    Diagnostics World Brief | GRAIL has raised over $900 million through the first close of its previously announced Series B financing, which was led by ARCH Venture Partners, and includes Johnson & Johnson Innovation as the largest investor in the financing.

    Mar 1, 2017
  • Genetic Lab Pays Doctors To Push Dubious Tests, Employees Say

    STAT | A STAT investigation found that Proove Biosciences studies are largely a ploy to boost revenues from genetic tests meant to guide the choice of pain drugs.

    Feb 28, 2017
  • Illumina, Veritas Genetics, MDxHealth, And More: News From February 2017

    Diagnostics World Brief | News, products, and partnerships from around the diagnostics community including news from Illumina, Veritas Genetics, MDxHealth, and more.

    Feb 28, 2017
  • Creating A Community To Advance Global Health Diagnostics

    The Huffington Post | Despite the critical importance of diagnosis, diagnostic testing and laboratory capacity receive much less attention than vaccines and drugs in the global health arena.

    Feb 24, 2017
  • Diagnostics World Announces Winner Of Inaugural Early Innovator Awards Program

    Diagnostics World | Diagnostics World has announced the winner of its first Diagnostics World Early Innovator Awards program. The winner was announced at the 2017 Molecular Medicine Tri Conference in San Fransisco.

    Feb 22, 2017
  • Is Watson Playing Sherlock? Artificial Intelligence In Diagnostic Medicine

    Diagnostics World | IBM’s Watson and other forms of artificial intelligence appear to be slowly shedding their sidekick status and taking on more prominent roles in solving today’s medical mysteries.

    Feb 21, 2017
  • Advanced Genomic Solutions Offers Their Health & Wellness Genetic Test On Amazon

    Diagnostics World Brief | Advanced Genomic Solutions announces that their Health & Wellness Genetic Test is now available on Amazon Prime for a reduced price of $450.

    Feb 17, 2017
  • GenePeeks Launches NGS Platform To Assess Potential Disorders In Children

    Diagnostics World | GenePeeks has launched its proprietary next-generation screening platform, which has the ability to assess the risk of conceiving a child with any one of more than 1,000 heritable genetic diseases.

    Feb 14, 2017
  • New Molecular Markers Fuel Diagnostic Development

    BioPharma Dive | While they may never command the eye-popping $250,000 price tag that some newer drugs do, there are still many experts who think there could be a Cinderella story for certain types of in vitro diagnostics.

    Feb 14, 2017
  • Quest Diagnostics And Veracyte Partner Up For Cancer Testing

    Diagnostics World Brief | Quest Diagnostics has recently entered into an agreement with genomic diagnostics company Veracyte, for the extended access of the latter's laboratory-developed test, Afirma Gene Expression Classifier.

    Feb 10, 2017
  • MDxHealth Awarded US Department Of Veterans Affairs Contract For ConfirmMDx Testing

    Diagnostics World Brief | MDxHealth today announced that it has been awarded a US Government Services Administration supply contract to use ConfirmMDx for Prostate Cancer within the Department of Veterans Affairs.

    Feb 8, 2017
  • «
  • 161
  • 162
  • 163
  • 164
  • 165
  • 166
  • 167
  • 168 (current)
  • 169
  • 170
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy